123 results on '"Pisano, David G."'
Search Results
102. Functional signatures identified in B-cell non-Hodgkin lymphoma profiles
- Author
-
Aggarwal, Mohit, primary, Sánchez-Beato, Margarita, additional, Aggarwal, Mohit, additional, Gómez-López, Gonzalo, additional, Al-Shahrour, Fátima, additional, Martínez, Nerea, additional, Rodríguez, Antonia, additional, Ruiz-Ballesteros, Elena, additional, Camacho, Francisca I., additional, Pérez-Rosado, Alberto, additional, de la Cueva, Paloma, additional, Artiga, María J., additional, Pisano, David G., additional, Kimby, Eva, additional, Dopazo, Joaquín, additional, Villuendas, Raquel, additional, and Piris, Miguel A., additional
- Published
- 2009
- Full Text
- View/download PDF
103. miR-181b negatively regulates activation-induced cytidine deaminase in B cells
- Author
-
de Yébenes, Virginia G., primary, Belver, Laura, additional, Pisano, David G., additional, González, Susana, additional, Villasante, Aranzazu, additional, Croce, Carlo, additional, He, Lin, additional, and Ramiro, Almudena R., additional
- Published
- 2008
- Full Text
- View/download PDF
104. Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs
- Author
-
Gonzalez, Susana, primary, Pisano, David G., additional, and Serrano, Manuel, additional
- Published
- 2008
- Full Text
- View/download PDF
105. The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource forfunctional studies.
- Author
-
Earl, Julie, Rico, Daniel, Carrillo-de-Santa-Pau, Enrique, Rodríguez-Santiago, Benjamín, Méndez-Pertuz, Marinela, Auer, Herbert, Gómez, Gonzalo, Grossman, Herbert Barton, Pisano, David G., Schulz, Wolfgang A., Pérez-Jurado, Luis A., Carrato, Alfredo, Theodorescu, Dan, Chanock, Stephen, Valencia, Alfonso, and Rea, Francisco X.
- Subjects
BLADDER cancer genetics ,CELL lines ,GENETIC mutation ,DNA copy number variations ,SINGLE nucleotide polymorphisms ,GENE expression - Abstract
Background: Urothelial bladder cancer is a highly heterogeneous disease. Cancer cell lines are useful tools for its study. This is a comprehensive genomic characterization of 40 urothelial bladder carcinoma (UBC) cell lines including information on origin, mutation status of genes implicated in bladder cancer (FGFR3, PIK3CA, TP53, and RAS), copy number alterations assessed using high density SNP arrays, uniparental disomy (UPD) events, and gene expression. Results: Based on gene mutation patterns and genomic changes we identify lines representative ofthe FGFR3-driven tumor pathway and ofthe TP53/RB tumor suppressor-driven pathway. High-density array copy number analysis identified significant focal gains (1q32, 5p13.1-12, 7q11, and 7q33) and losses (i.e. 6p22.1) in regions altered in tumors but not previously described as affected in bladder cell lines. We also identify new evidence for frequent regions of UPD, often coinciding with regions reported to be lost in tumors. Previously undescribed chromosome X losses found in UBC lines also point to potential tumor suppressor genes. Cell lines representative of the FGFR3-driven pathway showed a lower number of UPD events. Conclusions: Overall, there is a predominance of more aggressive tumor subtypes among the cell lines. We provide a cell line classification that establishes their relatedness to the major molecularly-defined bladder tumor subtypes. The compiled information should serve as a useful reference to the bladder cancer research community and should help to select cell lines appropriate for the functional analysis of bladder cancer genes, for example those being identified through massive parallel sequencing. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
106. Somatic Embryonic FGFR2Mutations in Keratinocytic Epidermal Nevi
- Author
-
Toll, Agustí, Fernández, Luis C., Pons, Tirso, Groesser, Leopold, Sagrera, Ana, Carrillo-de Santa Pau, Enrique, Vicente, Asunción, Baselga, Eulàlia, Vázquez, Miguel, Beltrán, Sergi, Pisano, David G., Rueda, Daniel, Gut, Marta, Pujol, Ramon M., Hafner, Christian, Gut, Ivo, Valencia, Alfonso, and Real, Francisco X.
- Published
- 2016
- Full Text
- View/download PDF
107. Genome-wide analysis of in vivo TRF1 binding to chromatin restricts its location exclusively to telomeric repeats.
- Author
-
Garrobo, Ianire, Marión, Rosa M, Domínguez, Orlando, Pisano, David G, and Blasco, Maria A
- Published
- 2014
- Full Text
- View/download PDF
108. ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors
- Author
-
Balbás-Martínez, Cristina, Rodríguez-Pinilla, María, Casanova, Ariel, Domínguez, Orlando, Pisano, David G., Gómez, Gonzalo, Lloreta, Josep, Lorente, José A., Malats, Núria, and Real, Francisco X.
- Subjects
BLADDER cancer ,FIBROBLAST growth factor receptors ,CANCER prognosis ,EPIGENETICS ,NUCLEOTIDE sequence ,ONCOLOGY - Abstract
Urothelial bladder cancer (UBC) is heterogeneous at the clinical, pathological, genetic, and epigenetic levels. Exome sequencing has identified ARID1A as a novel tumor suppressor gene coding for a chromatin remodeling protein that is mutated in UBC. Here, we assess ARID1A alterations in two series of patients with UBC. In the first tumor series, we analyze exons 2–20 in 52 primary UBC and find that all mutant tumors belong to the aggressive UBC phenotype (high grade non-muscle invasive and muscle invasive tumors) (P = 0.05). In a second series (n = 84), we assess ARID1A expression using immunohistochemistry, a surrogate for mutation analysis, and find that loss of expression increases with higher stage/grade, it is inversely associated with FGFR3 overexpression (P = 0.03) but it is not correlated with p53 overexpression (P = 0.30). We also analyzed the expression of cytokeratins in the same set of tumor and find, using unsupervised clustering, that tumors with ARID1A loss of expression are generally KRT5/6-low. In this patient series, loss of ARID1A expression is also associated with worse prognosis, likely reflecting the higher prevalence of losses found in tumors of higher stage and grade. The independent findings in these two sets of patients strongly support the notion that ARID1A inactivation is a key player in bladder carcinogenesis occurring predominantly in FGFR3 wild type tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
109. De Novo Assembly and Functional Annotation of the Olive (Olea europaea) Transcriptome.
- Author
-
Muñoz-Mérida, Antonio, González-Plaza, Juan José, Cañada, Andrés, Blanco, Ana María, García-López, Maria del Carmen, Rodríguez, José Manuel, Pedrola, Laia, Sicardo, M. Dolores, Hernández, M. Luisa, De la Rosa, Raúl, Belaj, Angjelina, Gil-Borja, Mayte, Luque, Francisco, Martínez-Rivas, José Manuel, Pisano, David G., Trelles, Oswaldo, Valpuesta, Victoriano, and Beuzón, Carmen R.
- Abstract
Olive breeding programmes are focused on selecting for traits as short juvenile period, plant architecture suited for mechanical harvest, or oil characteristics, including fatty acid composition, phenolic, and volatile compounds to suit new markets. Understanding the molecular basis of these characteristics and improving the efficiency of such breeding programmes require the development of genomic information and tools. However, despite its economic relevance, genomic information on olive or closely related species is still scarce. We have applied Sanger and 454 pyrosequencing technologies to generate close to 2 million reads from 12 cDNA libraries obtained from the Picual, Arbequina, and Lechin de Sevilla cultivars and seedlings from a segregating progeny of a Picual × Arbequina cross. The libraries include fruit mesocarp and seeds at three relevant developmental stages, young stems and leaves, active juvenile and adult buds as well as dormant buds, and juvenile and adult roots. The reads were assembled by library or tissue and then assembled together into 81 020 unigenes with an average size of 496 bases. Here, we report their assembly and their functional annotation. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
- Full Text
- View/download PDF
110. Whole genome analysis of p38 SAPK-mediatedgene expression upon stress.
- Author
-
Ferreiro, Isabel, Joaquin, Manel, Islam, Abul, Gomez-Lopez, Gonzalo, Barragan, Montserrat, Lombardía, Luís, Domínguez, Orlando, Pisano, David G., Lopez-Bigas, Nuria, Nebreda, Angel R., and Posas, Francesc
- Subjects
GENES ,GENOMES ,PROTEIN kinases ,CELLS ,PROTEINS - Abstract
Background: Cells have the ability to respond and adapt to environmental changes through activation of stressactivated protein kinases (SAPKs). Although p38 SAPK signalling is known to participate in the regulation of gene expression little is known on the molecular mechanisms used by this SAPK to regulate stress-responsive genes and the overall set of genes regulated by p38 in response to different stimuli. Results: Here, we report a whole genome expression analyses on mouse embryonic fibroblasts (MEFs) treated with three different p38 SAPK activating-stimuli, namely osmostress, the cytokine TNFα and the protein synthesis inhibitor anisomycin. We have found that the activation kinetics of p38α SAPK in response to these insults is different and also leads to a complex gene pattern response specific for a given stress with a restricted set of overlapping genes. In addition, we have analysed the contribution of p38a the major p38 family member present in MEFs, to the overall stress-induced transcriptional response by using both a chemical inhibitor (SB203580) and p38α deficient (p38α
-/- ) MEFs. We show here that p38 SAPK dependency ranged between 60% and 88% depending on the treatments and that there is a very good overlap between the inhibitor treatment and the ko cells. Furthermore, we have found that the dependency of SAPK varies depending on the time the cells are subjected to osmostress. Conclusions: Our genome-wide transcriptional analyses shows a selective response to specific stimuli and a restricted common response of up to 20% of the stress up-regulated early genes that involves an important set of transcription factors, which might be critical for either cell adaptation or preparation for continuous extra-cellular changes. Interestingly, up to 85% of the up-regulated genes are under the transcriptional control of p38 SAPK. Thus, activation of p38 SAPK is critical to elicit the early gene expression program required for cell adaptation to stress. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
111. Genome-wide analysis of in vivoTRF1 binding to chromatin restricts its location exclusively to telomeric repeats
- Author
-
Garrobo, Ianire, Marión, Rosa M, Domínguez, Orlando, Pisano, David G, and Blasco, Maria A
- Abstract
Telomeres are nucleoprotein structures at the ends of eukaryotic chromosomes that protect them from degradation, end-to-end fusions, and fragility. In mammals, telomeres are composed of TTAGGG tandem repeats bound by a protein complex called shelterin, which has fundamental roles in the regulation of telomere protection and length. The telomeric repeat binding factor 1 (TERF1 or TRF1) is one of the components of shelterin and has been shown to be essential for telomere protection. Telomeric repeats can also be found throughout the genome, as Internal or Interstitial Telomeric Sequences (ITSs). Some of the components of shelterin have been described to bind to ITSs as well as other extra-telomeric regions, which in the case of RAP1 exert a key role in transcriptional regulation. Here, we set to address whether TRF1 can be found at extra-telomeric sites both under normal conditions and upon induction of telomere shortening. In particular, we performed a ChIP-sequencing technique to map TRF1 binding sites in MEFs wild-type and deficient for the telomerase RNA component (Terc−/−), with increasingly short telomeres. Our findings indicate that TRF1 is exclusively located at telomeres both under normal conditions, as well as under extreme telomere shortening. These results indicate that in mice not all members of shelterin have extra-telomeric roles as it was described for RAP1.
- Published
- 2014
- Full Text
- View/download PDF
112. Select Your SNPs (SYSNPs): a web tool for automatic and massive selection of SNPs
- Author
-
Lorente-Galdos, Belén, Medina, Ignacio, Morcillo-Suarez, Carlos, Heredia, Txema, Carreño-Torres, Ángel, Sangrós, Ricardo, Alegre, Josep, Pita, Guillermo, Vellalta, Gemma, Malats, Nuria, Pisano, David G., Dopazo, Joaquín, and Navarro, Arcadi
- Abstract
Association studies are the choice approach in the discovery of the genomic basis of complex traits. To carry out such analysis, researchers frequently need to (1) select optimally informative sets of Single Nucleotide Polymorphisms (SNPs) in candidate regions and (2) annotate the results of associations found by means of genome-wide SNP arrays. These are complex tasks, since many criteria have to be considered, including the SNPs’ functional properties, technological information and haplotype frequencies in given populations. SYSNPs implements algorithms that allow for efficient and simultaneous consideration of all the relevant criteria to obtain sets of SNPs that properly cover arbitrarily large lists of genes or genomic regions. Complementarily, SYSNPs allows for comprehensive functional annotation of SNPs linked to any given marker SNP. SYSNPs dramatically reduces the effort needed for SNP selection from days of searching various databases to a few minutes using a simple browser.
- Published
- 2012
- Full Text
- View/download PDF
113. TCL1Aexpression delineates biological and clinical variability in B-cell lymphoma
- Author
-
Aggarwal, Mohit, Villuendas, Raquel, Gomez, Gonzalo, Rodriguez-Pinilla, Socorro M, Sanchez-Beato, Margarita, Alvarez, David, Martinez, Nerea, Rodriguez, Antonia, Castillo, Maria E, Camacho, Francisca I, Montes-Moreno, Santiago, Garcia-Marco, Jose A, Kimby, Eva, Pisano, David G, and Piris, Miguel A
- Abstract
The assembly of a collection of gene-expression signatures of the major types of B-cell non-Hodgkin's lymphoma has identified increased T-cell leukemia/lymphoma 1A (TCL1) expression in multiple lymphoma types and cases, and has enabled the investigation of the functional and clinical importance of TCL1 expression. Specifically, Burkitt's lymphoma cases show a homogeneously strong expression of TCL1, whereas diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, chronic lymphocytic leukemia, nodal marginal zone lymphoma, and splenic marginal zone lymphoma display a striking variability in the intensity of TCL1 staining. This was validated in two independent series. A Gene-Set Enrichment Analysis of the genes correlated with TCL1Aexpression found that variation in the level of expression of TCL1Awas significantly associated with some of the most important gene signatures recognizing B-cell lymphoma pathogenesis and heterogeneity, such as germinal center, B-cell receptor, NF-κB (and its target genes), death, MAP kinases, TNFR1, TOLL, and IL1R. Additionally, TCL1 expression was correlated with shorter time to treatment in chronic lymphocytic leukemia cases and shorter lymphoma-specific survival in mantle cell lymphoma series, thus indicating the clinical and biological significance of TCL1 expression, and suggesting TCL1A as a potential therapeutic target.
- Published
- 2009
- Full Text
- View/download PDF
114. An Intuitive Workflow to Retrieve Somatic Mutations in Next Generation Sequencing Studies
- Author
-
Daniel Glez-Peña, Reboiro-Jato, Miguel, Fdez-Riverola, Florentino, Pisano, David G., Gomez-Lopez, Gonzalo, Rocha, Mp, Rodriguez, Jmc, Fdezriverola, F., and Valencia, A.
115. Applying AIBench Framework to Develop Rich User Interfaces in NGS Studies
- Author
-
Lopez-Fernandez, Hugo, Glez-Pena, Daniel, Reboiro-Jato, Miguel, Gomez-Lopez, Gonzalo, Pisano, David G., Florentino Fdez-Riverola, Rocha, Mp, Luscombe, N., Fdezriverola, F., and Rodriguez, Jmc
116. Current Efforts to Integrate Biological Pathway Information
- Author
-
Glez-Pena, Daniel, Dominguez, Ruben, Gomez-Lopez, Gonzalo, Pisano, David G., Florentino Fdez-Riverola, Omatu, S., Rocha, Mp, Bravo, J., Fernandez, F., Corchado, E., Bustillo, A., and Corchado, Jm
117. Building a GATK-Based Tool for Methylation Analysis in Next-Generation Bisulfite Sequencing Experiments
- Author
-
Glez-Pena, Daniel, Grana, Osvaldo, Florentino Fdez-Riverola, Pisano, David G., Rocha, Mp, Rodriguez, Jmc, Fdezriverola, F., and Valencia, A.
118. The EMBRACE web service collection
- Author
-
Pettifer, Steve, Ison, Jon, Kalaš, Mat�š, Thorne, Dave, McDermott, Philip, Jonassen, Inge, Liaquat, Ali, Fern�ndez, Jos� M., Rodriguez, Jose M., Partners, INB, Pisano, David G., Blanchet, Christophe, Uludag, Mahmut, Rice, Peter, Bartaseviciute, Edita, Rapacki, Kristoffer, Hekkelman, Maarten, Sand, Olivier, Stockinger, Heinz, Clegg, Andrew B., Bongcam-Rudloff, Erik, Salzemann, Jean, Breton, Vincent, Attwood, Teresa K., Cameron, Graham, Vriend, Gert, Pettifer, Steve, Ison, Jon, Kalaš, Mat�š, Thorne, Dave, McDermott, Philip, Jonassen, Inge, Liaquat, Ali, Fern�ndez, Jos� M., Rodriguez, Jose M., Partners, INB, Pisano, David G., Blanchet, Christophe, Uludag, Mahmut, Rice, Peter, Bartaseviciute, Edita, Rapacki, Kristoffer, Hekkelman, Maarten, Sand, Olivier, Stockinger, Heinz, Clegg, Andrew B., Bongcam-Rudloff, Erik, Salzemann, Jean, Breton, Vincent, Attwood, Teresa K., Cameron, Graham, and Vriend, Gert
- Abstract
The EMBRACE (European Model for Bioinformatics Research and Community Education) web service collection is the culmination of a 5-year project that set out to investigate issues involved in developing and deploying web services for use in the life sciences. The project concluded that in order for web services to achieve widespread adoption, standards must be defined for the choice of web service technology, for semantically annotating both service function and the data exchanged, and a mechanism for discovering services must be provided. Building on this, the project developed: EDAM, an ontology for describing life science web services; BioXSD, a schema for exchanging data between services; and a centralized registry (http://www.embraceregistry.net) that collects together around 1000 services developed by the consortium partners. This article presents the current status of the collection and its associated recommendations and standards definitions
119. Epstein Barr Virus Micrornas Repress BCL6 Expression in Diffuse Large B Cell Lymphoma.
- Author
-
Marti´n-Pe´rez, Daniel, Vargiu, Pierfrancesco, Montes-Moreno, Santiago, Pisano, David G, Rodriguez-Pinilla, Maria Socorro, Rodri´guez, Rufo, Mollejo, Manuela, Castellvi, Josep, Sa´nchez-Beato, Margarita, and Piris, Miguel A.
- Abstract
Epstein Barr Virus (EBV) is able to transform B-cells by disrupting the normal B-cell differentiation programme, leading to the development of different types of B-cell lymphoma. BCL6 is a key transcriptional repressor during normal B-cell differentiation that is required for germinal centre reaction and it has been shown to repress NF-kB in Diffuse Large B-Cell Lymphoma (DLBCL). In some B-cell lymphomas the expression of BCL6 and infection with EBV are mutual exclusive occurrences, although the causal mechanism of this phenomenon and its biological significance remain elusive.A microRNA expression profile was investigated using Agilent's Human miRNA microarray kit. microRNA targets were predicted with the miRanda algorithm (http://www.microrna.org/). Immunohistochemical and in situ hybridization analyses were performed on 149 DLBCL samples to investigate the expression of BCL6 and EBV status, respectively. Luciferase assays were carried out by cloning the BCL6 3'-UTR into the pGL3-Control vector.22 viral microRNAs were found to be upregulated specifically in EBV-positive cases of DLBCL. By applying the miRanda algorithm, 10 of these 22 microRNAs were predicted potentially to target BCL6. To explore this possibility, immunohistochemical analysis and in situ hybridization were carried out on 149 cases of DLBCL. The results showed an almost perfect inverse correlation between BCL6 protein expression and EBV infection, even in the absence of LMP1 protein expression (p<0.001). Only one out of 34 EBV-positive cases expressed BCL6, although 87 out of 115 EBV-negative cases expressed BCL6. This phenomenon was confirmed in DLBCL cell lines. ebv-miR-BART3, ebv-miR-BART7, ebv-miR-BART9 and ebv-miR-BART17-5p were selected from the list of ten microRNAs for further functional validation, on the basis of the score calculated by miRanda. Thus, we transfected synthetic microRNAs and measured the luciferase activity in our reporter system. At least three of the assayed microRNAs were able to reduce the luciferase activity of the reporter. The effect of these microRNAs on the endogenous BCL6 protein was investigated in lymphoid BCL6-expressing cell lines by Western blot. The four microRNAs were able to downregulate the levels of endogenous BCL6.DLBCL cases infected by EBV express a restricted set of viral microRNAs. Several of these microRNAs can potentially target the BCL6 gene, highlighting the importance of BCL6 downregulation in the context of EBV infection. Functional studies demonstrate that at least three of these microRNAs are able to downregulate BCL6 expression. The reason why EBV downregulates BCL6 is still unknown, but we propose that it might be required for DLBCL cells to survive in the context of EBV-induced NF-?B pathway activation.No relevant conflicts of interest to declare.
- Published
- 2009
- Full Text
- View/download PDF
120. Prediction of miRNA-mRNA Interactions Using miRGate.
- Author
-
Andrés-León E, Gómez-López G, and Pisano DG
- Subjects
- 3' Untranslated Regions, Algorithms, Animals, Databases, Genetic, Gene Expression Regulation, Humans, Internet, Mice, Rats, Software, Genomics methods, MicroRNAs genetics, RNA, Messenger genetics
- Abstract
miRGate ( http://mirgate.bioinfo.cnio.es /) is a freely available database that contains predicted and experimentally validated microRNA-messenger RNA (miRNA-mRNA) target pairs. This resource includes novel predictions from five well-established algorithms, but recalculated from a common and comprehensive sequence dataset. It includes all 3'-UTR sequences of all known genes of the three more widely employed genomes (human, mouse, and rat), and all annotated miRNA sequences from those genomes. Besides, it also contains predictions for all genes in human targeted by miRNA viruses such as Epstein-Barr and Kaposi sarcoma-associated herpes virus.The approach intends to circumvent one of the main drawbacks in this area, as diverse sequences and gene database versions cause poor overlap among different target prediction methods even with experimentally confirmed targets. As a result, miRGate predictions have been successfully validated using functional assays in several laboratories.This chapter describes how a user can access target information via miRGate's web interface. It also shows how automatically access the database through the programmatic interface based on representational state transfer services (REST), using the application programming interface (API) available at http://mirgate.bioinfo.cnio.es/API .
- Published
- 2017
- Full Text
- View/download PDF
121. Identification of TERRA locus unveils a telomere protection role through association to nearly all chromosomes.
- Author
-
López de Silanes I, Graña O, De Bonis ML, Dominguez O, Pisano DG, and Blasco MA
- Subjects
- Animals, Cell Cycle genetics, Chromosomes, Mammalian metabolism, Embryo, Mammalian, Fibroblasts cytology, Fibroblasts metabolism, Gene Expression, Genes, Reporter, Genetic Loci, High-Throughput Nucleotide Sequencing, In Situ Hybridization, Fluorescence, Luciferases genetics, Luciferases metabolism, Mice, Primary Cell Culture, Protein Binding, RNA, Messenger metabolism, RNA-Binding Proteins genetics, Repetitive Sequences, Nucleic Acid, Telomere metabolism, Transcription Factors genetics, Chromosomes, Mammalian chemistry, Genome, RNA, Messenger chemistry, RNA-Binding Proteins metabolism, Telomere chemistry, Transcription Factors metabolism
- Abstract
Telomeric RNAs (TERRAs) are UUAGGG repeat-containing RNAs that are transcribed from the subtelomere towards the telomere. The precise genomic origin of TERRA has remained elusive. Using a whole-genome RNA-sequencing approach, we identify novel mouse transcripts arising mainly from the subtelomere of chromosome 18, and to a lesser extend chromosome 9, that resemble TERRA in several key aspects. Those transcripts contain UUAGGG-repeats and are heterogeneous in size, fluctuate in abundance in a TERRA-like manner during the cell cycle, are bound by TERRA RNA-binding proteins and are regulated in a manner similar to TERRA in response to stress and the induction of pluripotency. These transcripts are also found to associate with nearly all chromosome ends and downregulation of the transcripts that originate from chromosome 18 causes a reduction in TERRA abundance. Interestingly, downregulation of either chromosome 18 transcripts or TERRA results in increased number of telomere dysfunction-induced foci, suggesting a protective role at telomeres.
- Published
- 2014
- Full Text
- View/download PDF
122. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.
- Author
-
Ferreira PG, Jares P, Rico D, Gómez-López G, Martínez-Trillos A, Villamor N, Ecker S, González-Pérez A, Knowles DG, Monlong J, Johnson R, Quesada V, Djebali S, Papasaikas P, López-Guerra M, Colomer D, Royo C, Cazorla M, Pinyol M, Clot G, Aymerich M, Rozman M, Kulis M, Tamborero D, Gouin A, Blanc J, Gut M, Gut I, Puente XS, Pisano DG, Martin-Subero JI, López-Bigas N, López-Guillermo A, Valencia A, López-Otín C, Campo E, and Guigó R
- Subjects
- Aged, Base Sequence, Female, Gene Expression Profiling, Humans, Immunoglobulin Variable Region, Leukemia, Lymphocytic, Chronic, B-Cell pathology, Male, Middle Aged, Mutation, Ribosomes genetics, Spliceosomes genetics, B-Lymphocytes, Gene Expression Regulation, Neoplastic, High-Throughput Nucleotide Sequencing, Leukemia, Lymphocytic, Chronic, B-Cell genetics
- Abstract
Chronic lymphocytic leukemia (CLL) has heterogeneous clinical and biological behavior. Whole-genome and -exome sequencing has contributed to the characterization of the mutational spectrum of the disease, but the underlying transcriptional profile is still poorly understood. We have performed deep RNA sequencing in different subpopulations of normal B-lymphocytes and CLL cells from a cohort of 98 patients, and characterized the CLL transcriptional landscape with unprecedented resolution. We detected thousands of transcriptional elements differentially expressed between the CLL and normal B cells, including protein-coding genes, noncoding RNAs, and pseudogenes. Transposable elements are globally derepressed in CLL cells. In addition, two thousand genes-most of which are not differentially expressed-exhibit CLL-specific splicing patterns. Genes involved in metabolic pathways showed higher expression in CLL, while genes related to spliceosome, proteasome, and ribosome were among the most down-regulated in CLL. Clustering of the CLL samples according to RNA-seq derived gene expression levels unveiled two robust molecular subgroups, C1 and C2. C1/C2 subgroups and the mutational status of the immunoglobulin heavy variable (IGHV) region were the only independent variables in predicting time to treatment in a multivariate analysis with main clinico-biological features. This subdivision was validated in an independent cohort of patients monitored through DNA microarrays. Further analysis shows that B-cell receptor (BCR) activation in the microenvironment of the lymph node may be at the origin of the C1/C2 differences.
- Published
- 2014
- Full Text
- View/download PDF
123. Interoperability with Moby 1.0--it's better than sharing your toothbrush!
- Author
-
Wilkinson MD, Senger M, Kawas E, Bruskiewich R, Gouzy J, Noirot C, Bardou P, Ng A, Haase D, Saiz Ede A, Wang D, Gibbons F, Gordon PM, Sensen CW, Carrasco JM, Fernández JM, Shen L, Links M, Ng M, Opushneva N, Neerincx PB, Leunissen JA, Ernst R, Twigger S, Usadel B, Good B, Wong Y, Stein L, Crosby W, Karlsson J, Royo R, Párraga I, Ramírez S, Gelpi JL, Trelles O, Pisano DG, Jimenez N, Kerhornou A, Rosset R, Zamacola L, Tarraga J, Huerta-Cepas J, Carazo JM, Dopazo J, Guigo R, Navarro A, Orozco M, Valencia A, Claros MG, Pérez AJ, Aldana J, Rojano M, Fernandez-Santa Cruz R, Navas I, Schiltz G, Farmer A, Gessler D, Schoof H, and Groscurth A
- Subjects
- Systems Integration, Computational Biology methods, Database Management Systems, Databases, Factual, Information Storage and Retrieval methods, Internet, Programming Languages
- Abstract
The BioMoby project was initiated in 2001 from within the model organism database community. It aimed to standardize methodologies to facilitate information exchange and access to analytical resources, using a consensus driven approach. Six years later, the BioMoby development community is pleased to announce the release of the 1.0 version of the interoperability framework, registry Application Programming Interface and supporting Perl and Java code-bases. Together, these provide interoperable access to over 1400 bioinformatics resources worldwide through the BioMoby platform, and this number continues to grow. Here we highlight and discuss the features of BioMoby that make it distinct from other Semantic Web Service and interoperability initiatives, and that have been instrumental to its deployment and use by a wide community of bioinformatics service providers. The standard, client software, and supporting code libraries are all freely available at http://www.biomoby.org/.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.